Greg Tesch

Adj Assoc Prof

Accepting PhD Students

PhD projects

Therapeutic targeting of kidney tubular cells to inhibit tubulointerstitial fibrosis

1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Research Interests. Diabetes and hypertension are major causes of end-stage kidney disease. Dr Tesch’s research focuses on identifying the underlying mechanisms of inflammation and fibrosis that are involved in kidney and heart injury in patients with diabetes and hypertension. In particular, his work focuses on the role of macrophages, tubular cells, fibroblasts and cell signalling pathways in progressive tissue injury. His studies utilize a variety of experimental techniques to examine the molecular mechanisms of disease, including conditional gene deletion, pharmacological blockade of receptors or intracellular signalling kinases, combination therapies, and cell culture studies. He is also engaged in a collaboration to develop novel drug delivery systems to target specific cell types. His previous work has led to clinical trials using an inhibitor of either a chemokine receptor (CCR2) or a specific kinase (ASK1) to treat diabetic kidney disease. This has been achieved through collaborations with local and overseas researchers, and with a number of commercial companies.

Research opportunities. We have a variety of projects available for PhD students and post-doctoral scientists examining novel mechanisms of inflammation and fibrosis in kidney disease. Our lab has an active PhD student program with 4 current students at different stages of their studies.

Research area keywords

  • Chronic Kidney Disease (CKD)
  • Diabetic Kidney Disease (DKD)
  • Glomerulonephritis
  • Cell signalling
  • Inflammation
  • Diabetic complications
  • Fibrosis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney disease

Tesch, G. H., Ma, F. Y. & Nikolic-Paterson, D. J., 23 Jan 2020, (Accepted/In press) In : Anatomical Record. 8 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in Nos3-deficient mice

Tesch, G. H., Pullen, N., Jesson, M. I., Schlerman, F. J. & Nikolic-Paterson, D. J., 1 Dec 2019, In : American Journal of Physiology-Renal Physiology. 317, 6, p. F1439-F1449 11 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury

Tian, L., Nikolic-Paterson, D. J. & Tesch, G. H., 1 Sep 2019, In : Physiological Reports. 7, 18, 8 p., e14197.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
1 Citation (Scopus)

Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis

Han, Y., Tian, L., Ma, F., Tesch, G., Vesey, D. A., Gobe, G. C., Lohman, R. J., Morais, C., Suen, J. Y., Fairlie, D. P. & Nikolic-Paterson, D. J., 1 May 2019, In : Clinical and Experimental Pharmacology and Physiology. 46, 5, p. 456-464 9 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Proximal tubular epithelial cells preferentially endocytose covalently-modified albumin compared to native albumin

Ly, N. D. K., Tesch, G. H., Nikolic-Paterson, D. J. & Poronnik, P., Jan 2019, In : Nephrology. 24, 1, p. 121-126 6 p.

Research output: Contribution to journalArticleResearchpeer-review